The role of chemokines in controlling granulomatous inflammation in Schistosoma mansoni infection

Acta Tropica

Volumn 108, Issue 2-3, 2008, Pages 135-138

  Souza, Patrícia R S ^a   Souza, Adriano L S ^a   Negrão Correa, Deborah ^b   Teixeira, Antonio L ^a,c   Teixeira, Mauro M ^a  

^a Institute of Biological Sciences   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Faculty of Medicine   (Brazil)

Author keywords

Chemokines; Inflammation; Schistosomiasis

Indexed keywords

ACETYLGLUCOSAMINIDASE; CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; COLLAGEN ANTIBODY; EOSINOPHIL PEROXIDASE; HYDROXYPROLINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PARASITE ANTIGEN;

EGG; FLATWORM; IMMUNE RESPONSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; ENZYME ACTIVITY; GRANULOMATOUS INFLAMMATION; IMMUNOPATHOGENESIS; KNOCKOUT MOUSE; LEUKOCYTE MIGRATION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ANIMALS; CHEMOKINES; HUMANS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SEVERITY OF ILLNESS INDEX;

ANIMALIA; MUS; SCHISTOSOMA MANSONI;

EID: 56949086304     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2008.04.016     Document Type: Article

References (31)

1. Allen S.J., Crown S.E., and Handel T.M. Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25 (2007) 787-820
2. Bao L., Zhu Y., Zhu J., and Lindgren J.U. Decreased IgG production but increased MIP-1beta expression in collagen-induced arthritis in C-C chemokine receptor 5-deficient mice. Cytokine 31 (2005) 64-71
3. Booth M., Mwatha J.K., Joseph S., Jones F.M., Kadzo H., Ireri E., Kazibwe F., Kemijumbi J., Kariuki C., Kimani G., Ouma J.H., Kabatereine N.B., Vennervald B.J., and Dunne D.W. Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender. J. Immunol. 172 (2004) 1295-1303
4. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354 (2006) 610-621
5. Chensue S.W., Warmington K.S., Allenspach E.J., Lu B., Gerard C., Kunkel S.L., and Lukacs N.W. Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. J. Immunol. 163 (1999) 165-173
6. Chensue S.W., Lukacs N.W., Yang T.Y., Shang X., Frait K.A., Kunkel S.L., Kung T., Wiekowski M.T., Hedrick J.A., Cook D.N., Zingoni A., Narula S.K., Zlotnik A., Barrat F.J., O'Garra A., Napolitano M., and Lira S.A. Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice. J. Exp. Med. 193 (2001) 573-584
7. Falcão P.L., Correa-Oliveira R., Fraga L.A.O., Talvani A., Proudfoot A.E., Wells T.N.C., Williams T.J., Jose P.J., and Teixeira M.M. Plasma concentrations and role of macrophage inflammatory protein-1α (MIP-1α/CCL3) during chronic Schistosoma mansoni infection in humans. J. Infect. Dis. 186 (2002) 1696-1700
8. Fallon P.G. Immunopathology of schistosomiasis: a cautionary tale of mice and men. Immunol. Today 21 (2000) 29-35
9. Gao J.L., Wynn T.A., Chang Y., Lee E.J., Broxmeyer H.E., Cooper S., Tiffany H.L., Wespahl H., Kwon-Chung J., and Murphy P.M. Impaired host defense, hematopoiesis, granulomatous inflammation, and type 1-type 2, cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185 (1997) 1959-1968
10. Jakubzick C., Wen H., Matsukawa A., Keller M., Kunkel S.L., and Hogaboam C.M. Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice. Am. J. Pathol. 165 (2004) 1211-1221
11. Lukacs N.W., Kunkel S.L., Strieter R.M., Warmington K., and Chensue S.W. The role of macrophage inflammatory protein-1 alpha in Schistosoma mansoni egg-induced granulomatous inflammation. J. Exp. Med. 177 (1993) 1551-1559
12. Machado F.S., Koyama N.S., Carregaro V., Ferreira B.R., Milanezi C.M., Teixeira M.M., Rossi M.A., and Silva J.S. CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi. J. Infect. Dis. 191 (2005) 627-636
13. Mackay C.R. Chemokines: immunology's high impact factors. Nat. Immunol. 2 (2001) 95-101
14. Maurer M., and von Stebut E. Macrophage inflammatory protein-1. Int. J. Biochem. Cell Biol. 36 (2004) 1882-1886
15. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., Miller L.H., Oppeinheim J.J., and Power C.A. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52 (2000) 145-176
16. Nibbs R.J., Wylie S.M., Pragnell I.B., and Graham G.J. Cloning and characterization of a novel murine beta chemokine receptor, D6. Comparison to three other related macrophage inflammatory protein-1alpha receptors, CCR-1, CCR-3, and CCR-5. J. Biol. Chem. 272 (1997) 12495-12504
17. Olson T.S., and Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 (2002) R7-28
18. Post T.W., Bozic C.R., Rothenberg M.E., Luster A.D., Gerard N., and Gerard C. Molecular characterization of two murine eosinophil beta chemokine receptors. J. Immunol. 155 (1995) 5299-5305
19. Proudfoot A.E., Power C.A., Rommel C., and Wells T.N. Strategies for chemokine antagonists as therapeutics. Semin. Immunol. 15 (2003) 57-65
20. Purandare A.V., and Somerville J.E. Antagonists of CCR4 as immunomodulatory agents. Curr. Top. Med. Chem. 6 (2006) 1335-1344
21. Qiu B., Frait K.A., Reich F., Komuniecki E., and Chensue S.W. Chemokine expression dynamics in mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. Am. J. Pathol. 158 (2001) 1503-1515
22. Sousa-Pereira S., Teixeira A.L., Silva L.C., Souza A.L., Antunes C.M., Teixeira M.M., and Lambertucci J.R. Serum and cerebral spinal fluid levels of chemokines and Th2 cytokines in Schistosoma mansoni myeloradiculopathy. Parasite Immunol. 28 (2006) 473-478
23. Souza A.L., Sousa-Pereira S.R., Teixeira M.M., Lambertucci J.R., and Teixeira A.L. The role of chemokines in Schistosoma mansoni infection: insights from human disease and murine models. Mem. Inst. Oswaldo Cruz 101 Suppl. 1 (2006) 333-338
24. Souza A.L., Roffê E., Pinho V., Souza D.G., Silva A.F., Russo R.C., Guabiraba R., Pereira C.A., Carvalho F.M., Barsante M.M., Corrêa-Oliveira R., Fraga L.A., Negrão-Corrêa D., and Teixeira M.M. Potential role of the chemokine macrophage inflammatory protein 1alpha in human and experimental schistosomiasis. Infect. Immun. 73 (2005) 2515-2523
25. Teixeira M.M., Gazzinelli R.T., and Silva J.S. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol. 18 (2002) 262-265
26. Vierboom M.P., Zavodny P.J., Chou C.C., Tagat J.R., Pugliese-Sivo C., Stritzki J., Steensma R.W., McCombie S.W., Celebi-Paul L., Remarque E., Jonker M., Narula S.K., and Hart B. Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5. Arthritis Rheum. 52 (2005) 627-636
27. Warmington K.S., Boring L., Ruth J.H., Sonstein J., Hogaboam C.M., Curtis J.L., Kunkel S.L., Charo I.R., and Chensue S.W. Effect of C-C chemokine receptor 2 (CCR2) knockout on type-2 (schistosomal antigen elicited) pulmonary granuloma formation: analysis of cellular recruitment and cytokine responses. Am. J. Pathol. 154 (1999) 1407-1416
28. Wells T.N., Power C.A., Shaw J.P., and Proudfoot A.E. Chemokine blockers-therapeutics in the making?. Trends Pharmacol. Sci. 27 (2006) 41-47
29. Welniak L.A., Wang Z., Sun K., Kuziel W., Anver M.R., Blazar B.R., and Murphy W.J. An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease. Exp. Hematol. 32 (2004) 318-324
30. Yurchenko E., Tritt M., Hay V., Shevach E.M., Belkaid Y., and Piccirillo C.A. CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J. Exp. Med. 203 (2006) 2451-2460
31. Zhou Y., Kurihara T., Ryseck R.P., Yang Y., Ryan C., Loy J., Warr G., and Bravo R. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J. Immunol. 160 (1998) 4018-4025